Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outlook Therapeutics (OTLK) Shares Issued (2016 - 2025)

Outlook Therapeutics (OTLK) has disclosed Shares Issued for 8 consecutive years, with $14.9 million as the latest value for Q4 2025.

  • On a quarterly basis, Shares Issued rose 756.97% to $14.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $39.8 million, a 241.51% increase, with the full-year FY2025 number at $25.4 million, down 57.91% from a year prior.
  • Shares Issued was $14.9 million for Q4 2025 at Outlook Therapeutics, up from $8.1 million in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $15.1 million in Q1 2025 to a low of $1.7 million in Q4 2024.